Cargando…
Hepatoprotective effect of sitagliptin against methotrexate induced liver toxicity
Sitagliptin is selective dipeptidyl peptidase-4 inhibitor (DPP4-I), used clinically as a new oral anti-diabetic agent. This study explored the underlying mechanisms of the hepatoprotective role of sitagliptin pretreatment against methotrexate (MTX) induced hepatotoxicity in mice. Forty mice were div...
Autores principales: | Abo-Haded, Hany M., Elkablawy, Mohamed A., Al-johani, Zeyad, Al-ahmadi, Osama, El-Agamy, Dina S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363865/ https://www.ncbi.nlm.nih.gov/pubmed/28334048 http://dx.doi.org/10.1371/journal.pone.0174295 |
Ejemplares similares
-
Pristimerin as a Novel Hepatoprotective Agent Against Experimental Autoimmune Hepatitis
por: El-Agamy, Dina S., et al.
Publicado: (2018) -
Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK/NF-kB signaling pathways
por: El-Agamy, Dina S, et al.
Publicado: (2018) -
Assessment of quality of life among parents of children with congenital heart disease using WHOQOL-BREF: a cross-sectional study from Northwest Saudi Arabia
por: Khoshhal, Saad, et al.
Publicado: (2019) -
Cytokine Profiling among Children with Multisystem Inflammatory Syndrome versus Simple COVID-19 Infection: A Study from Northwest Saudi Arabia
por: Abo-Haded, Hany M., et al.
Publicado: (2022) -
Cardiac Functions Assessment in Children with Celiac Disease and its Correlation with the Degree of Mucosal Injury: Doppler Tissue Imaging Study
por: Fathy, Abeer, et al.
Publicado: (2016)